IJRTI
International Journal for Research Trends and Innovation
International Peer Reviewed & Refereed Journals, Open Access Journal
ISSN Approved Journal No: 2456-3315 | Impact factor: 8.14 | ESTD Year: 2016
Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 8.14 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

Call For Paper

For Authors

Forms / Download

Published Issue Details

Editorial Board

Other IMP Links

Facts & Figure

Impact Factor : 8.14

Issue per Year : 12

Volume Published : 9

Issue Published : 93

Article Submitted : 9866

Article Published : 5018

Total Authors : 13224

Total Reviewer : 557

Total Countries : 93

Indexing Partner

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License
Published Paper Details
Paper Title: THE REVIEW ON ROLE OF IMMUNOMODULATORS IN TREATMENT RESISTANT DEPRESSION
Authors Name: Priyanka Vilas Ponde , Pallavi Tukaram Jadhav
Download E-Certificate: Download
Author Reg. ID:
IJRTI_184406
Published Paper Id: IJRTI2210066
Published In: Volume 7 Issue 10, October-2022
DOI:
Abstract: The whole conditions associated with the raise or lowering a person’s mood such as depression. It is characterised by determined sadness and lack of interest or pleasure in previously satisfying or enjoyable activities. It can also disturb the sleep and appetite. Chemicals in our brain called neurotransmitter, play an important part in the mood. The primary treatment for severe depression we used serotonin norepinephrine reuptake inhibitor, fluoxetine, ketamine, cytokines, curcumin. The major depression can lead to a range of behavioural and physical syndrome. These may include changes in energy level, concentration or self-esteem. It is associated with thoughts of suicide.
Keywords: Depression, Treatment resistance, diseases, immune system, major depressive disorder, neurotransmission, cytokines, serotonin, central nervous system.
Cite Article: "THE REVIEW ON ROLE OF IMMUNOMODULATORS IN TREATMENT RESISTANT DEPRESSION", International Journal of Science & Engineering Development Research (www.ijrti.org), ISSN:2455-2631, Vol.7, Issue 10, page no.496 - 502, October-2022, Available :http://www.ijrti.org/papers/IJRTI2210066.pdf
Downloads: 000202604
ISSN: 2456-3315 | IMPACT FACTOR: 8.14 Calculated By Google Scholar| ESTD YEAR: 2016
An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.14 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator
Publication Details: Published Paper ID: IJRTI2210066
Registration ID:184406
Published In: Volume 7 Issue 10, October-2022
DOI (Digital Object Identifier):
Page No: 496 - 502
Country: Ahmednagar, Maharastra, India
Research Area: Pharmacy
Publisher : IJ Publication
Published Paper URL : https://www.ijrti.org/viewpaperforall?paper=IJRTI2210066
Published Paper PDF: https://www.ijrti.org/papers/IJRTI2210066
Share Article:

Click Here to Download This Article

Article Preview
Click Here to Download This Article

Major Indexing from www.ijrti.org
Google Scholar ResearcherID Thomson Reuters Mendeley : reference manager Academia.edu
arXiv.org : cornell university library Research Gate CiteSeerX DOAJ : Directory of Open Access Journals
DRJI Index Copernicus International Scribd DocStoc

ISSN Details

ISSN: 2456-3315
Impact Factor: 8.14 and ISSN APPROVED
Journal Starting Year (ESTD) : 2016

DOI (A digital object identifier)


Providing A digital object identifier by DOI.ONE
How to Get DOI?

Conference

Open Access License Policy

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License

Creative Commons License This material is Open Knowledge This material is Open Data This material is Open Content

Important Details

Social Media

Join RMS/Earn 300

IJRTI

Indexing Partner